About Imanova
Imanova is a company based in London (United Kingdom) founded in 2011 was acquired by Invicro in September 2017.. Imanova offers products and services including Imaging Core Lab, Clinical Adjudication, Preclinical Imaging, eClinical, and Radiochemistry. Imanova operates in a competitive market with competitors including GSK, Avidity Biosciences, Vividion Therapeutics, Korro Bio and Sutro Biopharma, among others.
- Headquarter London, United Kingdom
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Imanova Limited
- Date of Incorporation 03 Feb, 2011
- Jurisdiction LONDON, UNITED KINGDOM
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Imanova
Imanova offers a comprehensive portfolio of products and services, including Imaging Core Lab, Clinical Adjudication, Preclinical Imaging, eClinical, and Radiochemistry. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Delivers high-quality imaging data for clinical trials worldwide.
Conducts independent reviews of trial event assessments by experts.
Supports imaging study designs for pharmaceutical R&D needs.
Offers RTSM solutions for efficient clinical trial operations.
Provides radiolabeling for agents in drug development processes.
Funding Insights of Imanova
- Total Funding Total Funding
- Total Rounds 1
- Last Round Grant — $305,722
-
First Round
First Round
(01 Jun 2016)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2016 | Amount | Grant - Imanova | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Imanova
Imanova has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Invicro and European Union. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Founded Year | Domain | Location | |
|
Provide contract research imaging services and software
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Imanova
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Imanova
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Imanova Comparisons
Competitors of Imanova
Imanova operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GSK, Avidity Biosciences, Vividion Therapeutics, Korro Bio and Sutro Biopharma, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of pharmaceuticals and vaccines for various therapeutic areas
|
|
| domain | founded_year | HQ Location |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| domain | founded_year | HQ Location |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| domain | founded_year | HQ Location |
RNA-editing technologies are provided for precision medicine applications.
|
|
| domain | founded_year | HQ Location |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| domain | founded_year | HQ Location |
Therapeutics for rare respiratory diseases are developed by Savara Pharma.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Imanova
When was Imanova founded?
Imanova was founded in 2011 and raised its 1st funding round 5 years after it was founded.
Where is Imanova located?
Imanova is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
What does Imanova do?
Imanova, acquired by US-based Invicro in September 2017, enables the study of the absorption, distribution, metabolism and excretion of drugs through their expertise in radiolabeling of drug candidates and Positron Emission Tomography (PET) imaging. They also offer services for visualising the candidate target engagement in vivo through PET imaging. The company also offers MRI services. Founded as a joint venture between UKs Medical Research Council and three London universities - the Imperial College London, Kings College London and University College London, the company offers preclinical and clinical imaging and novel imaging biomarker development services. Imanova claims to have developed and implemented 21 imaging biomarkers according to GMP standards since its inception. The company offer imaging biomarker development services mainly for therapeutic areas such as neurosciences, oncology, inflammation, cardiology and respiratory diseases.
Who are the top competitors of Imanova?
Imanova's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
What products or services does Imanova offer?
Imanova offers Imaging Core Lab, Clinical Adjudication, Preclinical Imaging, eClinical, and Radiochemistry.
Who are Imanova's investors?
Imanova has 2 investors. Key investors include Invicro, and European Union.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.